132 related articles for article (PubMed ID: 26003539)
1. Correlation between BRCA1 and TopBP1 protein expression and clinical outcome of non-small cell lung cancer treated with platinum-based chemotherapy.
Wang LR; He LJ; Wang Y; Li YY; Lou Y; Zhang GB; Li Y; Chen J
Cancer Chemother Pharmacol; 2015 Jul; 76(1):163-70. PubMed ID: 26003539
[TBL] [Abstract][Full Text] [Related]
2. [Relationship between the protein expression of ERCC1, BRCA, β-tubulin and K-ras and the efficacy and prognosis in advanced non-small cell lung cancer].
Zhang L; Liu T; Zhang JQ
Zhonghua Zhong Liu Za Zhi; 2011 Mar; 33(3):212-6. PubMed ID: 21575522
[TBL] [Abstract][Full Text] [Related]
3. [Chinese multicenter randomized trial of customized chemotherapy based on BRCA1 (breast cancer susceptibility gene 1)-RAP80 (receptor-associated protein 80) mRNA expression in advanced non-small cell lung cancer (NSCLC) patients].
Wei J; Qian XP; Zou ZY; Wang LF; Yu LX; You CW; Song Y; Lu HY; Hu WJ; Yan J; Xu XX; Chen XF; Li XY; Wu QF; Zhou Y; Zhang FL; Liu BR
Zhonghua Zhong Liu Za Zhi; 2016 Nov; 38(11):868-873. PubMed ID: 27998448
[No Abstract] [Full Text] [Related]
4. Two biomarker-directed randomized trials in European and Chinese patients with nonsmall-cell lung cancer: the BRCA1-RAP80 Expression Customization (BREC) studies.
Moran T; Wei J; Cobo M; Qian X; Domine M; Zou Z; Bover I; Wang L; Provencio M; Yu L; Chaib I; You C; Massuti B; Song Y; Vergnenegre A; Lu H; Lopez-Vivanco G; Hu W; Robinet G; Yan J; Insa A; Xu X; Majem M; Chen X; de Las Peñas R; Karachaliou N; Sala MA; Wu Q; Isla D; Zhou Y; Baize N; Zhang F; Garde J; Germonpre P; Rauh S; ALHusaini H; Sanchez-Ronco M; Drozdowskyj A; Sanchez JJ; Camps C; Liu B; Rosell R; ; Colinet B; De Grève J; Germonpré P; Chen H; Chen X; Du J; Gao Y; Hu J; Hu W; Kong W; Li L; Li R; Li X; Liu B; Liu J; Lu H; Qian X; Ren W; Song Y; Wang L; Wei J; Wen L; Wu Q; Xiao X; Xu X; Yan J; Yang J; Yang M; Yang Y; Yin J; You C; Yu L; Yue X; Zhang F; Zhang J; Zhou Y; Zhu L; Zou Z; Baize N; Bombaron P; Chouaid C; Dansin E; Fournel P; Fraboulet G; Gervais R; Hominal S; Kahlout S; Lecaer H; Lena H; LeTreut J; Locher C; Molinier O; Monnet I; Oliviero G; Robinet G; Schoot R; Thomas P; Vergnènegre A; Berchem G; Rauh S; Al Husaini H; Aparisi F; Arriola E; Ballesteros I; Barneto I; Bernabé R; Blasco A; Bosch-Barrera J; Bover I; Calvo de Juan V; Camps C; Carcereny E; Catot S; Cobo M; De Las Peñas R; Dómine M; Felip E; García-Campelo MR; García-Girón C; García-Gómez R; Garcia-Sevila R; Garde J; Gasco A; Gil J; González-Larriba JL; Hernando-Polo S; Jantus E; Insa A; Isla D; Jiménez B; Lianes P; López-López R; López-Martín A; López-Vivanco G; Macias JA; Majem M; Marti-Ciriquian JL; Massuti B; Montoyo R; Morales-Espinosa D; Morán T; Moreno MA; Pallares C; Parera M; Pérez-Carrión R; Porta R; Provencio M; Reguart N; Rosell R; Rosillo F; Sala MA; Sanchez JM; Sullivan I; Terrasa J; Trigo JM; Valdivia J; Viñolas N; Viteri S; Botia-Castillo M; Mate JL; Perez-Cano M; Ramirez JL; Sanchez-Rodriguez B; Taron M; Tierno-Garcia M; Mijangos E; Ocaña J; Pereira E; Shao J; Sun X; O'Brate R
Ann Oncol; 2014 Nov; 25(11):2147-2155. PubMed ID: 25164908
[TBL] [Abstract][Full Text] [Related]
5. Tubulin, BRCA1, ERCC1, Abraxas, RAP80 mRNA expression, p53/p21 immunohistochemistry and clinical outcome in patients with advanced non small-cell lung cancer receiving first-line platinum-gemcitabine chemotherapy.
Joerger M; deJong D; Burylo A; Burgers JA; Baas P; Huitema AD; Beijnen JH; Schellens JH
Lung Cancer; 2011 Nov; 74(2):310-7. PubMed ID: 21529986
[TBL] [Abstract][Full Text] [Related]
6. Predictive value of APE1, BRCA1, ERCC1 and TUBB3 expression in patients with advanced non-small cell lung cancer (NSCLC) receiving first-line platinum-paclitaxel chemotherapy.
Li Z; Qing Y; Guan W; Li M; Peng Y; Zhang S; Xiong Y; Wang D
Cancer Chemother Pharmacol; 2014 Oct; 74(4):777-86. PubMed ID: 25107571
[TBL] [Abstract][Full Text] [Related]
7. ERCC1/BRCA1 expression and gene polymorphisms as prognostic and predictive factors in advanced NSCLC treated with or without cisplatin.
Tiseo M; Bordi P; Bortesi B; Boni L; Boni C; Baldini E; Grossi F; Recchia F; Zanelli F; Fontanini G; Naldi N; Campanini N; Azzoni C; Bordi C; Ardizzoni A;
Br J Cancer; 2013 Apr; 108(8):1695-703. PubMed ID: 23549037
[TBL] [Abstract][Full Text] [Related]
8. Prognostic value of cyclooxygenase-2 gene polymorphisms in advanced non-small cell lung cancer patients treated with first-line platinum-based chemotherapy.
Liu L; Zhou F; Ren S; Chen X; Li X; Li W; Zhou C
Asia Pac J Clin Oncol; 2016 Jun; 12(2):e339-46. PubMed ID: 25131817
[TBL] [Abstract][Full Text] [Related]
9. Expression of RRM1 and RRM2 as a novel prognostic marker in advanced non-small cell lung cancer receiving chemotherapy.
Wang L; Meng L; Wang XW; Ma GY; Chen JH
Tumour Biol; 2014 Mar; 35(3):1899-906. PubMed ID: 24155212
[TBL] [Abstract][Full Text] [Related]
10. Clinical significance of hypoxia-inducible factor-1a messenger RNA expression in locally advanced non-small-cell lung cancer after platinum agent and gemcitabine chemotherapy followed by surgery.
Felip E; Taron M; Rosell R; Mendez P; Queralt C; Ronco MS; Sanchez JJ; Sanchez JM; Maestre J; Majo J
Clin Lung Cancer; 2005 Mar; 6(5):299-303. PubMed ID: 15845181
[TBL] [Abstract][Full Text] [Related]
11. High-level mRNA of excision repair cross-complementation group 1 gene is associated with poor outcome of platinum-based doublet chemotherapy of advanced nonsmall cell lung cancer patients.
Ren S; Zhou S; Zhang L; Xu J; Lv M; Zhang J; Zhou C; Zhang J
Cancer Invest; 2010 Dec; 28(10):1078-83. PubMed ID: 20504223
[TBL] [Abstract][Full Text] [Related]
12. RRM1 gene expression in peripheral blood is predictive of shorter survival in Chinese patients with advanced non-small-cell lung cancer treated by gemcitabine and platinum.
Wang LR; Zhang GB; Chen J; Li J; Li MW; Xu N; Wang Y; Shen Tu JZ
J Zhejiang Univ Sci B; 2011 Mar; 12(3):174-9. PubMed ID: 21370501
[TBL] [Abstract][Full Text] [Related]
13. RRM1 and ERCC1 expression in peripheral blood versus tumor tissue in gemcitabine/carboplatin-treated advanced non-small cell lung cancer.
Zhang GB; Chen J; Wang LR; Li J; Li MW; Xu N; Wang Y; Shentu JZ
Cancer Chemother Pharmacol; 2012 May; 69(5):1277-87. PubMed ID: 22302408
[TBL] [Abstract][Full Text] [Related]
14. Clinical Significance of ABCG2 Haplotype-tagging Single Nucleotide Polymorphisms in Patients With Unresectable Non-Small Cell Lung Cancer Treated With First-line Platinum-based Chemotherapy.
Kim SH; Kim MJ; Cho YJ; Jeong YY; Kim HC; Lee JD; Hwang YS; Kim IS; Lee S; Oh SY; Ling H; Lee GW
Am J Clin Oncol; 2015 Jun; 38(3):294-9. PubMed ID: 23689644
[TBL] [Abstract][Full Text] [Related]
15. The role of expression and polymorphism of the BAG-1 gene in response to platinum-based chemotherapeutics in NSCLC.
Wang YD; Ha MW; Cheng J; Zhang WL; Cong X; Tong CY; Sun J
Oncol Rep; 2012 Apr; 27(4):979-86. PubMed ID: 22179630
[TBL] [Abstract][Full Text] [Related]
16. First-line gemcitabine plus cisplatin in nonsmall cell lung cancer patients.
Li Y; Wang LR; Chen J; Lou Y; Zhang GB
Dis Markers; 2014; 2014():960458. PubMed ID: 24591771
[TBL] [Abstract][Full Text] [Related]
17. The tailored chemotherapy based on RRM1 immunohistochemical expression in patients with advanced non-small cell lung cancer.
Nie X; Cheng G; Ai B; Zhang S
Cancer Biomark; 2013 Jan; 13(6):433-40. PubMed ID: 24595080
[TBL] [Abstract][Full Text] [Related]
18. Comparison of cisplatin- and carboplatin-based third-generation chemotherapy in 1,014 Chinese patients with advanced non-small-cell lung cancer.
Luo J; Leaw SJ; Xu Y; Zheng D
Med Oncol; 2011 Dec; 28(4):1418-24. PubMed ID: 20661668
[TBL] [Abstract][Full Text] [Related]
19. Adding gemcitabine to paclitaxel/carboplatin combination increases survival in advanced non-small-cell lung cancer: results of a phase II-III study.
Paccagnella A; Oniga F; Bearz A; Favaretto A; Clerici M; Barbieri F; Riccardi A; Chella A; Tirelli U; Ceresoli G; Tumolo S; Ridolfi R; Biason R; Nicoletto MO; Belloni P; Veglia F; Ghi MG
J Clin Oncol; 2006 Feb; 24(4):681-7. PubMed ID: 16446341
[TBL] [Abstract][Full Text] [Related]
20. Expression of DNA repair and replication genes in non-small cell lung cancer (NSCLC): a role for thymidylate synthetase (TYMS).
Kotoula V; Krikelis D; Karavasilis V; Koletsa T; Eleftheraki AG; Televantou D; Christodoulou C; Dimoudis S; Korantzis I; Pectasides D; Syrigos KN; Kosmidis PA; Fountzilas G
BMC Cancer; 2012 Aug; 12():342. PubMed ID: 22866924
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
